A Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Oral Doses of IX-01 in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 02 May 2014
Price : $35 *
At a glance
- Drugs IX 01 (Primary)
- Indications Premature ejaculation
- Focus Adverse reactions
- Sponsors Ixchelsis
- 26 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 04 Mar 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 03 Dec 2013 New trial record